The latest medical research on Public Health Medicine

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about public health medicine gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access

COVID-19: a brief update for radiologists.


Coronavirus disease 2019 (COVID-19), which is caused by a new coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-is a pandemi...

Are all voices heard in the COVID-19 debate?


The COVID-19 pandemic has vast global consequences. Yet, effective mitigation strategies and economic and medical outfall differ extensively across...

Impact of lockdown during COVID-19 pandemic on annual effective dose equivalent values of natural gamma radiation.


The study aimed to determine the impact of COVID-19 on values of annual effective dose equivalent of the natural gamma dose rate of Balod, Durg and...

Mental Health and the COVID-19 Crisis: The Hopes and Concerns for Children as Schools Re-open.


The COVID-19 crisis has affected everyone, especially elementary school-aged children who might be too young to fully understand the sudden changes...

Analysis of second outbreak of COVID-19 after relaxation of control measures in India.


At present, more and more countries have entered the parallel stage of fighting the epidemic and restoring the economy after reaching the inflectio...

COVID-19 Highlighting Inequalities in Access to Healthcare in England: A Case Study of Ethnic Minority and Migrant Women.


Our commentary aims to show that the COVID-19 pandemic has amplified existing barriers to healthcare in England for ethnic minority and migrant wom...

Thermovaccination, thermoheliox as a stimulant of immune response. Kinetic model of process development.


A kinetic model is proposed to describe the key features of development of an acute viral infection, accumulation of antibodies, and immune respons...

The Post-Pandemic World: between Constitutionalized and Authoritarian Orders - China's Narrative-Power Play in the Pandemic Era.


The paper aims to address the development of China's narrative power during the COVID-19 pandemic and its impact on world order. It argues that in ...

Experience on how to implement a preanalytical and POCT unit in Madrid's IFEMA field hospital during this unprecedented COVID-19 emergency.


To fight the virus SARS-CoV-2 spread to Europe from China and to give support to the collapsed public health system, the Spanish Health Authorities...

Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.


The 2019 Coronavirus disease (COVID-19) has been characterized as a pandemic, representing a serious global public health emergency. Serological tests have been proposed as reliable tools for detecting Coronavirus SARS-CoV-2 antibodies in infected patients, especially for surveillance or epidemiological purposes. The aim of this study is to evaluate the agreement between the IgM/IgG rapid assays, based on lateral flow immunochromatographic assay, and the fully automated 2019-nCoV IgM and IgG, based on chemiluminescence immunoassay.

SARS-CoV-2 antibodies were measured with the BIOSYNEX COVID-19 BSS IgM/IgG test (BIOSYNEX, Illkirch-Graffenstaden, France) and the MAGLUMI CLIA (IgM and IgG) (SNIBE - Shenzhen New Industries Biomedical Engineering, Shenzhen, China) in 70 serum samples from patients with PCR-confirmed diagnosis. The strength of the agreement of the two methods was calculated by using the Cohen Kappa index.

The results showed a good grade of concordance between the two immunoassays with a Cohen's kappa coefficient of 0.71 (95%CI: 0.54-0.87) for IgG SARS-CoV-2 antibodies and 0.70 (95%CI: 0.53-0.87) for IgM SARS-CoV-2 antibodies. In addition, the rapid assays BIOSYNEX COVID-19 BSS for detecting SARS-CoV-2 antibodies showed a positive likelihood ratio (LR) of 10.63 (95%CI: 2.79-40.57) for IgG and a LR of 6.79 (95%CI: 2.93-15.69) for IgM.

Our results suggest that the immunochromatographic rapid IgM/IgG test and the chemiluminescence IgM and IgG immunoassay have a good degree of concordance, suggesting that both could be considered as useful tools for epidemiologic surveillance.

COVID-19 Creating another problem? Sustainable solution for PPE disposal through LCA approach.


Amid COVID-19, there have been rampant increase in the use of Personal Protective Equipment (PPE) kits by frontline health and sanitation communiti...

"AndrĂ  tutto bene": Associations Between Character Strengths, Psychological Distress and Self-efficacy During Covid-19 Lockdown.


The Covid-19 pandemic obliged people around the world to stay home and self-isolate, with a number of negative psychological consequences. This stu...